Mike Drummond

Search results

• 2008

  Economic Evaluation of Adolescent Addiction Programs: Methodologic Challenges and Recommendations

  Homer, J. F., Drummond, M. F. & French, M. T., Dec 2008, In: Journal of Adolescent Health. 43, 6, p. 529-539 11 p.

  Research output: Contribution to journal › Literature review › peer-review

• Evolution of the health economics of cervical cancer vaccination

  Ferko, N., Postma, M., Gallivan, S., Kruzikas, D. & Drummond, M., 15 Sept 2008, In: Vaccine. 26, SUPPL.5, p. F3-F15 13 p.

  Research output: Contribution to journal › Literature review › peer-review

• Guidelines for conducting pharmaceutical budget impact analyses for submission to public drug plans in Canada

  Marshall, D. A., Douglas, P. R., Drummond, M. F., Torrance, G. W., MacLeod, S., Manti, O., Cheruvu, L. & Corvari, R., 2008, In: Pharmacoeconomics. 26, 6, p. 477-495 19 p.

  Research output: Contribution to journal › Literature review › peer-review

• Systematic reviews and economic evaluations conducted for the National Institute for Health and Clinical Excellence in the United Kingdom: A game of two halves?

  Drummond, M. F., Iglesias, C. P. & Cooper, N. J., Apr 2008, In: International Journal of Technology Assessment in Health Care. 24, 2, p. 146-150 5 p.

  Research output: Contribution to journal › Literature review › peer-review
• 2007

  Do we fully understand the economic value of vaccines?

  Drummond, M., Chevat, C. & Lothgren, M., 10 Aug 2007, In: Vaccine. 25, 32, p. 5945-5957 13 p.

  Research output: Contribution to journal › Literature review › peer-review
• 2005

  Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: A systematic review and economic evaluation

  Wilby, J., Kainth, A., Hawkins, N., Epstein, D., McIntosh, H., McDaid, C., Mason, A., Golder, S., O'Meara, S., Sculpher, M., Drummond, M. & Forbes, C., May 2005, In: Health technology assessment. 9, 15, 158 p.

  Research output: Contribution to journal › Literature review › peer-review

  Open Access

  File

• Economic factors associated with antithrombotic treatments for stroke prevention in patients with atrial fibrillation

  Miller, P. S. J., Drummond, M. F., Langkilde, L. K., McMurray, J. J. V. & Ogren, M., May 2005, In: European heart journal supplements. 7, C, p. C41-C54 14 p.

  Research output: Contribution to journal › Literature review › peer-review

• 1997

  Pharmacoeconomics: Integrating economic evaluation into clinical trials

  Haycox, A., Drummond, M. & Walley, T., Jun 1997, In: British journal of clinical pharmacology. 43, 6, p. 559-562 4 p.

  Research output: Contribution to journal › Literature review › peer-review

• 1993

  ECONOMIC-EVALUATION OF PHARMACEUTICALS - A EUROPEAN PERSPECTIVE

  Drummond, M., Rutten, F., Brenna, A., Pinto, C. G., Horisberger, B., Jonsson, B., Lepen, C., Rovira, J., Vonderschulenburg, M. G., Sintonen, H. & Torfs, K., Sept 1993, In: Pharmacoeconomics. 4, 3, p. 173-186 14 p.

  Research output: Contribution to journal › Literature review › peer-review

• 1992

  BASING PRESCRIPTION DRUG PAYMENT ON ECONOMIC-ANALYSIS - THE CASE OF AUSTRALIA

  Drummond, M. F., 1992, In: Health Affairs. 11, 4, p. 191-196 6 p.

  Research output: Contribution to journal › Literature review › peer-review